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Abstract
Our understanding of the pathogenesis of “tendinopathy” is based on fragmented evidences like pieces of a jigsaw
puzzle. We propose a “failed healing theory” to knit these fragments together, which can explain previous observa-
tions. We also propose that albeit “overuse injury” and other insidious “micro trauma” may well be primary triggers
of the process, “tendinopathy” is not an “overuse injury” per se. The typical clinical, histological and biochemical
presentation relates to a localized chronic pain condition which may lead to tendon rupture, the latter attributed
to mechanical weakness. Characterization of pathological “tendinotic” tissues revealed coexistence of collagenolytic
injuries and an active healing process, focal hypervascularity and tissue metaplasia. These observations suggest a
failed healing process as response to a triggering injury. The pathogenesis of tendinopathy can be described as a
three stage process: injury, failed healing and clinical presentation. It is likely that some of these “initial injuries”
heal well and we speculate that predisposing intrinsic or extrinsic factors may be involved. The injury stage
involves a progressive collagenolytic tendon injury. The failed healing stage mainly refers to prolonged activation
and failed resolution of the normal healing process. Finally, the matrix disturbances, increased focal vascularity and
abnormal cytokine profiles contribute to the clinical presentations of chronic tendon pain or rupture. With this inte-
grative pathogenesis theory, we can relate the known manifestations of tendinopathy and point to the “missing
links”. This model may guide future research on tendinopathy, until we could ultimately decipher the complete
pathogenesis process and provide better treatments.
Introduction
In the past decades, our concepts on chronic tendon
pain have evolved from “tendinitis” which focused on
clinical inflammatory signs, into “tendinosis” which
stressed the pathologic features of the free tendon as
observed by histology and biochemistry, and then “ten-
dinopathy” which declared nothing further about its nat-
ure, just introducing a new label for chronic tendon and
insertion problems in general [1]. Woo and Renstrom
[2] concludes that the pathogenesis, etiology and
mechanisms in most of the myriads of conditions
related to tendinopathy are unknown. However, with
clear definitions outlining and discriminating the various
diagnoses of “tendinopathy”, it is still possible to pro-
pose a unified model for the pathogenesis based on
available experimental evidences, which we propose as
o u rt h e o r yt ob ep r o v e do rr e j e c t e db yf u t u r e
investigation.
In general, tendinopathy is characterized by longstand-
ing localized activity-related pain and the patients in
general respond poorly to most “conservative treat-
ments”. However, a wide spectrum of tendon patholo-
gies is put under the umbrella entity of tendinopathy
based on some common features [3] (Table 1), leading
to an impression that there is no single general patho-
genesis or aetiology involved which can explain all con-
ditions. If so, we firmly believe that these pathologies
should be classified as different entities. As the current
research evidences are confusing, it is very important to
identify if there are common denominators and diversi-
fiers for various manifestations of what we loosely call
“tendinopathy” to help us understand the pathogeneses
of these conditions.
In this article, we review previous investigations
according to the nature of the studies, for example, clin-
ical observations, characterization of clinical samples,
evaluation of treatments to patients with tendinopathy,
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related to the effects of risk factors. Certainly we do not
answer all questions with the integration of various
research evidences, but we take the bold step to propose
an integrative theory for the pathogenesis of tendinopa-
thy based on the underlying messages in these studies.
Clinical observations of tendinopathy
To understand the pathogenesis of what today is labeled
as “tendinopathy” we have to make some clear distinc-
tions. Firstly we must consider the varying clinical pre-
sentations. Most tendon problems are presented to the
clinician either as a rupture or localized pain, often
including stiffness and swelling. Symptomatic tendinopa-
thy refers to chronic localized pain with “degenerative”
changes in tendons as observed by imaging or histology;
while asymptomatic tendinopathy is identified from rup-
tures or partial rupture cases shown to be associated
with non symptomatic pre-existing degenerative
changes. Pathologies primarily manifested as passive loss
of range of motion (i.e. triggerf i n g e r ,f r o z en shoulder,
etc) are not considered as tendinopathy in this discus-
sion. Dating back to 1938, Codman reported degenera-
tion in complete ruptures of rotator cuff [4]. Kannus
and Josza reported in 1991 from a large number of his-
tological samples that an absolute majority of patients
with complete Achilles tendon ruptures had pathologic
alterations which he described as “mucoid degeneration”
[5]. This “mucoid degeneration” is almost equivalent to
the histological alterations characterized for tendinosis
[6]. It is very likely that these pathological changes in
tendons imposed mechanical weakness and higher sus-
ceptibility to ruptures. Similar histopathological charac-
teristics were also described in clinical samples of
symptomatic tendinopathy [7,8]. It suggests that the
“typical” histopathological changes characterized by ten-
don degeneration may not necessarily be directly linked
to increased nociception giving the patients warning sig-
nals; while in painful cases, the mechanically weaker
tendons may be protected from ruptures due to
decreased impact levels since painful activities will be
avoided.
Secondly, we must consider the etiology and epide-
miology. Unfortunately, well defined epidemiological
studies on “tendinopathy” are virtually nonexistent. Age-
related changes in tendons were reported [9], but tendi-
nopathy is not an age-related degeneration because
similar pathological changes are observed in young peo-
ple [10]. Higher number of cases in males presented in
clinical studies [11,12] may not reflect higher suscept-
ibility of male gender to tendinopathy; on the contrary,
it is reported that female gender was more susceptible
to repetitive trauma in rotator cuff [13] and female
cyclists suffer a higher risk for “overuse injury” in gen-
eral than their male counterparts [14]. There were sig-
nificant gender differences in tendon microcirculation
[15] and the neuropeptide responsiveness in rabbit ten-
don explants was influenced by gender and pregnancy
[16]. Diabetes [17] and metabolic alterations such as dis-
lipidemia [18] has been proposed as risk factor for
developing tendinopathy. These findings suggest that
the hormonal background may affect the development
Table 1 Involvement of failed healing in different manifestations of tendinopathies
Injury Healing responses Failed
Healing
Histopathological changes Clinical
presentation
Different
manifestations
￿ Overuse
￿ Previous traumatic
injury
￿ Xenobiotics
￿ Pathogens
Inflammation ⇒ Sustained pro-inflammatory
cytokines
￿ Pain
￿ Mechanical
weakness
￿“ Tendinitis”
￿ Paratendinitis
￿ Insertional
tendinopathy
￿ Overuse tendon
injuries
￿ Spontaneous
rupture
￿ Activity-related pain
￿ Calcified
tendinopathy
Neovascularization ⇒ Hypervascularity
Innervation ⇒ Increased neuropeptides and
innervation
Cell recruitment/apoptosis ⇒ Hypercellularity, increased
apoptosis
Matrix synthesis ⇒ Mucoid, lipoid, calcific
degeneration
Tenogenic differentiation/
apoptosis
⇒
Matrix remodeling ⇒ Collagenolysis, tendon adhesion
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oids [20] were found to be associated with Achilles ten-
don ruptures; suggesting pharmacological influence on
the development of tendon pathology. Overuse, repeti-
tive strain or mechanical overload to tendons are con-
sidered as primary trigger of symptomatic tendinopathy
in various regions [21], as implied by the names such as
“jumper’sk n e e ”, “runner’sh e e l ”, “swimmer’ss h o u l d e r ”
and “tennis elbow”. The prevalence of supraspinatous
tendinopathy could be as high 69 % in elite swimmers
[22]. However, there are frequent tendinopathy cases
(pain or rupture) in the non-athlete population [23,20].
Thus overuse injury should not be equated to tendino-
pathy, but it may be one of the major triggers of the
pathological development in some individuals. Further-
more, overuse as a risk factor for tendinopathy is not
simply a quantitative increase in activities, but may also
be attributed to improper gait or training errors [24,25].
Thirdly, the anatomical sites of tendinopathic
changes add further complexity. Since overuse or
cumulative trauma may also affect other peritendinous
tissues, tendinopathy was sometimes presented with
pathological changes in tenosynovium, bursa and
nerves. Our discussion on the pathogenesis of tendino-
pathy should be focused on changes primarily initiated
and observed in tendons; otherwise the pathogenesis
pathways will be very heterogeneous. It follows that
infectious tenosynovitis, bursitis, adhesive capsulitis or
tendon and nerve entrapment in case of carpel tunnel
syndrome will not be included in our model, but
“paratenonitis” [26] and “insertional tendinopathies”
[27] will be discussed since they are parts of a tendon.
The pathological changes in different forms of tendi-
nopathy are localized in different regions of the
affected tendons, for example, the proximal deep pos-
terior portion of the patellar tendon is affected in
patellar tendinopathy, while mid-substance or insertion
pathological changes can be observed in Achilles tendi-
nopathy. The medial musculotendinous junction or lat-
eral Humerus insertion was affected in Rotator cuff
tendinopathy, while in lateral epicondylitis the fascial
collagen structure on the extensor carpi radialis brevis
tendon was pathological. Based on the involvement of
pathological changes in the paratenon, different sub-
classes can be further identified in Achilles tendinopa-
thy [28]. Owing to these variations in the sites of
pathological changes, it suggests the common denomi-
nator of the pathogenesis of tendinopathy may prob-
ably involve a process that can affect all parts of
tendons [29], including musculotendinous junction,
mid-substance, insertion and paratenons. The “com-
munication” between these structures around the ten-
dons is poorly investigated.
Medical imaging of tendinopathy
Tendinopathy exhibited characteristic pathological
changes which are visible under ultrasound or magnetic
resonance imaging (MRI). Tendon thickening or swel-
ling is revealed, localized hypoechogenic signals were
detected by ultrasound [30] and an increased T1 and T2
contrast signal was shown by MRI [31,32]. It suggests
an increased water content which is probably related to
increased accumulation of water-retaining proteoglycans.
Doppler ultrasound imaging showed increased vascular-
ity and blood flow in the pathological regions but the
oxygen tension was not significantly different [33].
These findings suggested an inflammatory component
[34] with localized changes in the tendinous matrix and
hypervascularity may be associated with the pathogen-
esis of tendinopathy.
Characterization of clinical samples of
tendinopathy
Direct investigation of tendinopathy started with histolo-
gical examination of the pathological tissues. Classical
characteristics of “tendinosis” include degenerative
changes in the collagenous matrix, hypercellularity,
hypervascularity and a lack of inflammatory cells which
has challenged the original misnomer “tendinitis” [35,6].
Further characterizations are basically extrapolation of
these findings, for examples, measurement of prolifera-
tion and apoptosis to explain the changes in cellularity
[36,37], detection of extracellular matrix components
[38-41], collagen crosslink [42] and degradative enzymes
[43,44] to explain the matrix disturbances, and detection
of the expression of various cytokines to account for the
deregulation of cellular activities [45,46]. Calcified tendi-
nitis exhibited abnormal tendon calcification which is
more common in rotator cuffs [47]. Recently, the find-
ings of increased innervations [48] and nociceptive sub-
stances [49,50] suggest that the chronic pain of
tendinopathy may directly be resulted from the patholo-
gical changes. The findings of increased apoptosis
[51,52] and acquisition of chondrogenic phenotypes [53]
in the injured tendons suggested a disturbance in cell
differentiation. Increased proteoglycans with over-sul-
phation [40] and expression of different versican variant
[54] may be related to abnormal chondrogenesis in the
affected tendons. In contrast to early observations of a
lack of inflammatory cells [11], increased mast cell num-
ber was reported in human patellar tendinopathy [55].
Researchers are well aware of the limitation of the clini-
cal samples, which may represent only the end-stage of
the pathological processes with unknown duration and
onset. Nevertheless, these observations have provided
some direct clues to work out the pathogenesis of tendi-
nopathy, and these histopathological characteristics are
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thy [56-58]. It should be noted that some of these
pathological characteristics are sustained healing
responses that failed to repair the initial injury, such as
increased cell proliferation and elevated cytokines,
which is also implicated in the normal healing process,
as shown in the active remodeling sites in healthy ten-
dons [59]. The histopathological features of tendinopa-
thy we observed in animal models must be chronic and
cannot be resolved spontaneously as compared to the
normal course of tendon healing.
Genetic predisposition of tendinopathy
The possible genetic predisposition for Achilles tendino-
pathy has been investigated. It was found that variants
within COL5A1 [60], tenascin C [61] and matrix metal-
loproteinase 3 (MMP3) gene [62] was associated with
increased risk of Achilles tendon injuries in general.
Since these genes are related to homeostasis of extracel-
lular matrix in tendons, it is suggested that the genetic
variants modify the susceptibility of tendons to matrix
disturbance observed in tendinopathy.
Evaluation of interventions to tendinopathy
The observed pathological changes of tendinopathy
intuitively provided a lot of insights for the treatments.
However, all current treatment methods may not signifi-
cantly affect the natural history of the disease [63]. Sur-
gical excision was reported to be used on animals over
many years, in particular on horses [64]. Surgical exci-
sion of pathological tissues [65,66] and percutaneous
multiple longitudinal incisions [67,68] were reported to
be effective to relieve the symptoms similar to open
excision of macroscopic pathologic tendon structures
[23]. But ultrasonographic anomalies may still be evi-
dent in the healing tissues after surgical excision of
pathological tissues; despite the painful symptoms were
relieved [69]. Thus the current understanding of the
relationship of structural changes and functional impair-
ments is still inadequate to assure the degenerative fea-
tures as specific “markers” for tendinopathy. Biophysical
intervention such as extracorporeal shockwave therapy
exhibited significant improvement especially for calcified
tendinopathy [70,71]. It suggests that the pathological
tissues might be responsive to mechanical stimulation.
The observed effects of eccentric exercise for tendinopa-
thy [72,73] also implied that a proper modulation of
mechanical environment may exert positive effects on
the diseased tendons, such as an increase in peritendi-
nous collagen synthesis [74]. Other biophysical interven-
tions included ultrasound therapy [75-77], pulsed
magnetic field therapy [78,79], low level laser therapy
[80-82], radiofrequency [83] and acupuncture [84].
These studies claimed that modulation of inflammatory
or neuronal components in the pathological tissues may
exert beneficial effects. There are also reports on the
use of nitric oxide [85], sclerosing agents [86,87], MMP
inhibitors [88], bone marrow plasma injection [89],
autologous blood injection [90,91] or platelet-rich
plasma [92-94] for tendinopathy. Stem cell therapy was
tried in horse models [95]. These studies may suggest
the involvement of disturbances in cytokines, neovascu-
larization, innervations or cell differentiation in the
pathogenesis of tendinopathy.
Animal models of tendinopathy
The lack of a representative animal model is a major
obstacle for tendinopathy research. Recent reviews dis-
cussed current animal models used for tendinopathy
research [96-98], including cytokine-induced tendon
injuries [58,99,100], collagenase-induced injury
[56,101-105] and overuse induced injury [57,106-110].
Generally, histopathological characteristics derived from
clinical samples are the main criteria for evaluation of
tendinopathic changes. Ultrasonographic features were
occasionally used in horse models [111], and some stu-
dies reported pain-associated behavioral changes asso-
ciated with the tendon injuries [112,113]. These animal
models were established according to different hypoth-
eses of pathogenesis, and aimed at reproducing the clini-
cal signs of tendinopathy as far as possible. The use of
cytokines to induce pathological changes implied the
key roles of one or several cytokines in the development
of the disease; while collagenase injection mimicked the
pathological processes from the point when progressive
matrix degradation was dominating. These chemically-
induced tendinopathy models may reveal different start-
ing points of the pathological process but the causes of
increased cytokines or collagenases must be linked with
clinically relevant etiological factors. Moreover, the
acute induction of degenerative changes in these models
cannot reflect the chronic development of the disease.
On the other hand, animal models of overuse tendon
injuries gained wide acceptance for the demonstration
of the relationship between the mechanical overload and
the development of histopathological changes
[57,109,110] and increase in pro-inflammatory mediators
[51,114,115]. Although overuse is sufficient to generate
degenerative changes over a longer period of time, this
form of injuries can be healed when the overuse training
was ceased [116]; while in clinical cases of tendinopathy
the symptoms were not improved by rest. Obviously,
overuse tendon injury does not equate to tendinopathy.
The failed healing response to the injuries caused by
mechanical overload of tendons should also be consid-
ered in the establishment of animal model of tendino-
pathy. With respect to the variability in clinical
manifestation of tendinopathy, most animal models may
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may only represent one of the possible pathways from
the generation of injuries to development of tendinopa-
thy features (Table 1). In summary, it appears that
degenerative tendon injuries can be resulted from repe-
titive strain injuries that exceed the normal thresholds
(overuse); while abnormal levels of cytokines and col-
lagenases could be the effectors to mediate this kind of
degenerative injuries.
Cell culture studies of effects of risk factors on
tendinopathy
Cell culture studies of tendinopathy included the char-
acterization of abnormal activities in the cells isolated
from pathological tissues of tendinopathy [36,44,45,53],
and the studies in normal cultured tendon cells in
response to potential risk factors such as mechanical
strain [117-123] and xenobiotics [124-129]. In cell cul-
tures of tendinopathy tissues, the abnormal cellular
activities were persistent during sub-cultures, indicating
relatively stable cell phenotypes that are significantly
different from tendon fibroblasts derived from healthy
tendons [36,45]. On the other hand, numerous
studies showed that repetitive mechanical stimulation
can affect production of pro-inflammatory mediators
[117,118,120-123,130], metalloproteinases [123,131] and
matrix syntheses [119] in cultured tendon fibroblasts;
while non-tenogenic differentiation of tendon derived
stem cells can also be triggered by mechanical stretching
[132]. Corticosteroids also induced fibrocartilage pheno-
type in tendon cells [129], affected matrix synthesis
[127], cell viability [126,128] and apoptosis [133]. Fluor-
oquinolones may also activate metalloproteinases in ten-
don cells and hence collagenolytic injuries [125]. These
observations implied that activation of collagenolysis
and erroneous differentiation may weaken the mechani-
cal properties of tendons [134]. Interestingly, non-steroi-
dal anti-inflammatory drugs (NSAIDs) also modulate
tendon cell proliferation [124,135], the expression of
extracellular matrix components [124] and degradative
enzymes [136]. As NSAID is commonly used for sports-
related injuries and symptoms, it is possible that anti-
inflammatory treatment used for overuse injury may
contribute to the development of tendinopathy [137]
which is normally diagnosed after NSAID treatment was
failed.
Previous theories of pathogenesis of
tendinopathy
Several theories of pathogenesis of tendinopathy have
been proposed to explain the development of the histo-
pathological features observed in the clinical samples of
tendinopathy. Burry suggested that tendon lesions were
not resolved properly and resulted in degenerative
changes already in 1978 [138]. However, further elabora-
tion of the idea of “improper resolution of tendon
lesion” was not possible due to a lack of experimental
evidences at that time. Leadbetter and Khan et al. have
suggested that “tendinosis” are degenerative changes
resulting from increased demand on tendons with
inadequate repair and progressive cell death [139,140].
This model explained the generation of overuse injury,
and the reasons for inadequate repair are attributed to
adaptive response to tissue overload as elaborated by
Kibler and Sorosky et al [141,142]. However, “inade-
quate repair” as quantitative decrease in healing cells
cannot explain the findings of focal hypercellularity,
active proliferation and metaplasia in tendinopathy sam-
ples. The “apoptosis theory” [143-145] proposed by
Murrell also neglect the fact of increased cellularity; but
this hypothesis linked up oxidative stress, acquisition of
cartilage phenotype and activation of metalloproteinase
with the development of degenerative injuries by high
dose of cyclic strain. Unfavorable mechanical stimula-
tion as repetitive tensile strain [120], stress-shielding
[146], contractile tension overloads [147] or compres-
sion [148] was proposed as noxious triggers on tendon
cells to induce tendon inflammation or degenerative
changes. These theories pointed out that the interac-
tions between tendon cells and their mechanical envir-
onment were deterministic for the pathogenesis. On the
other hand, Pufe et al. suggested that hypoxia and
increased vascular in-growth into tendons may be the
causes of tendon weakening and ruptures [149], while
Riley provided a neurogenic hypothesis to explain the
adaptive responses to mechanical overload by nerve and
mast cells unit [150] and Fredberg et al. suggested neu-
rogenic inflammation may be involved in the pathogen-
esis pathway [151]. These theories were formulated
according to the findings of hypervascularity and
increased innervations. In summary, the common motifs
in these pathogenesis theories include unfavorable
mechanical loading, adaptive cellular responses (includ-
ing tendon, blood vessels and nerves) and the generation
of histopathological features. In our opinion, it is possi-
ble to unify these ideas as “failed healing”, which may be
the integral part of various pathological processes that
divert various tendon injuries into its different manifes-
tations of tendinopathy. (Table 1)
A unified theory of pathogenesis of tendinopathy
Based on the information of various lines of investiga-
tion of tendinopathy, we can summarize some major
points which must be considered in the formulation of
the pathogenesis model of tendinopathy:
1. The interactions of tendon injuries and unfavorable
mechanical environment would be the starting point of
the pathological process. Instead of coining the phrase
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“adaptive healing responses to tendon injuries” would be
a more comprehensive descriptor, which also includes
vascular, neural and peri-tendinous reactions at different
stages of healing.
2. The normal healing processes are diverted to an
abnormal pathway, probably due to unfavorable
mechanical environment, disturbances of local inflam-
matory responses, oxidative stress or pharmacological
influences. Therefore, the healing capacity is not only
inadequate but also incorrect and deviated from an ideal
healing outcome.
3. The primary results of pathology are the progressive
collagenolytic injuries co-existing with a failed healing
response, thus both degenerative changes and active
healing are observed in the pathological tissues.
4. These pathological tissues may aggravate the noci-
ceptive responses by various pathways which are no
longer responsive to conventional treatment such as
inhibition of prostaglandin synthesis; otherwise the insi-
dious mechanical deterioration without pain may render
increased risk of ruptures.
Based on these points, we propose that the pathogen-
esis of tendinopathy can be perceived as a 3-stages pro-
cess: injury, failed healing and clinical presentation. The
first stage does not involve pathological changes and
normal healing response could occur. The second stage
is relatively insidious and discriminated from the third
stage when clinical presentations are evident, such as
ruptures or chronic pain, often resistant to conservative
treatments.
Our theory of the pathogenesis of tendinopathy is
summarized in Figure 1.
Stage 1. Injury
In the first stage, initiation of tendinopathy may involve
generation of collagenolytic injuries. Overuse can evoke
the release of pro-inflammatory mediators [115], which
would result in stimulation of metalloproteinases and
hence collagenolytic injuries [152,153]. Recent findings
showed that the expression of MMP and tissue inhibitor
of metalloproteinase (TIMP) in tendon cells were sensi-
tive to mechanical overload or stress-deprivation
[131,154]. MMP inhibitor suppressed development of
mechanical weakness induced by stress-deprivation
[155]. Chemicals such as fluoroquinolone can induce
tendon cell death [156], oxidative damages [157] and
collagenolysis [125]. A previous traumatic injury that
has not been healed may also be susceptible to failed
healing [158]. With the case reports of infectious
Figure 1 Failed healing theory for the pathogenesis of tendinopathy.
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generate tendon injuries and inflammation could not be
ruled out. Tendon pain and mechanical weakness is not
s i g n i f i c a n ta tt h i ss t a g ea n di ti sp o s s i b l ef o rt h et e n d o n
injury to heal spontaneously.
Stage 2. Failed healing
In the failed healing stage, healing responses were acti-
vated but failed to repair the collagenolytic injuries. The
exact causes for failed healing are still obscured. It is
speculated that unfavorable mechanical environment,
genetic pre-disposition, hormonal background and phar-
macological exposures may affect the healing process.
Since tendon healing includes many sequential processes
such as inflammation, neovascularization, neural modula-
tions [160], recruitment of healing cells, proliferation,
apoptosis [161], matrix synthesis, tenogenic differentia-
tion and matrix remodeling; disturbances occurred at
different stages of healing may lead to different combina-
tions of histopathological changes as what we observed
in the clinical samples of tendinopathy (Table 1). Inflam-
matory responses are presumably elicited as the initial
stage of tissue repair, but it may not be properly resolved
under hostile mechanical environment or pharmacologi-
cal intervention such as NSAIDs, resulting in elevated
pro-inflammatory cytokines and a lack of ordinary
inflammatory infiltration in the diseased tissues. Depend-
ing on the anatomical variations of the affected tendons,
peritendinous reactions may be resulted as restrictive
fibrosis, increased innervations and vascular in-growth
from para-tenon structures may also take part in healing
process [162]. The sustained activation of tendon pro-
genitor cells with unfavorable micro-milieu for tendo-
genic differentiation may prone to erroneous
differentiation into fibrochondrogenic [163] or calcifying
phenotypes [104], which are normally confined to the
regions of bone-tendon junctions. Tendon pain becomes
significant and conservative treatments such as NSAIDs
are prescribed to the patients, which may further modify
the pathways of the failed healing.
Stage 3. Clinical presentation
In the third stage, symptomatic tendinopathy is diag-
nosed as longstanding, activity-related pain with charac-
teristic medical images; while spontaneous ruptures are
resulted from mechanical weakness under normal activ-
ities in cases of asymptomatic tendinopathy. The conse-
quences of failed healing to collagenolytic injuries
involve significant changes in extracellular matrix, which
are then visible under ultrasound or MRI. In sympto-
matic cases, inflammatory p a i nm a yb ei n v o l v e da n d
controlled during the injury and failed healing stages,
but the pain mechanism may gradually shift to non-
phlogistic ones such as agitation to peritendinous nerves
by nociceptive substances or swelling, rendering the
resistance to common anti-inflammatory treatments.
Though mechanical weakness may be involved in
asymptomatic cases [164], lower activities due to pain
may reduce risk of ruptures. In asymptomatic cases, the
matrix disturbance resulted from failed healing may not
activate nociceptive response. The insidious deteriora-
tion in mechanical properties of the affected tendons
may lead to ruptures. Owing to different combinations
of etiological factors, temporal and spatial variations on
the failed healing, the clinical manifestations of tendino-
pathy may exhibit high variability.
Explicability of the theory
With this theory for the pathogenesis of tendinopathy,
we can explain the process of the generation of the
pathological features of tendinopathy we observed in the
clinical samples. The theory is in accordance with most
of the evidences derived from tendinopathy studies. For
example, overuse is a major etiological factor but there
are tendinopathy patients without obvious history of
repetitive injuries. It is possible that non-overuse tendon
injuries may also be exposed to risk factors for failed
healing and entered to the third stage of tendinopathy.
Overuse induces collagenolytic tendon injuries and it
also imposes repetitive mechanical strain which may be
unfavorable for normal healing. Stress-deprivation also
induces MMP expression and whether over- or under-
stimulation is still an active debate [165]. It is possible
that tenocyte is responsive to both over- and under-
stimulation, both tensile and compressive loading.
Because the cellular responses of healing tendon cells
change in different stages of tendon healing [166], we
speculate that the cell responsiveness to mechanical
loading may not be constant during tendon healing and
failed healing may be resulted from a mismatch of heal-
ing stages and the mechanical environment. Our theory
can also explain why animal models of collagenase-
induced injuries can reproduce the histopathological
characteristics and functional impairment similar to ten-
dinopathy; despite the generation of collagenolytic inju-
ries in these models are completely different from the
insidious onset of tendinopathy. By proposing a process
of failed healing to translate tendon injuries into tendi-
nopathy, other extrinsic and intrinsic factors would
probably enter the play at this stage, such as genetic
predisposition, age [167], xenobiotics (NSAIDs and cor-
ticosteroids) and mechanical loading on the tendons.
For example, differential tensile forces acting on patellar
tendon [168] may impose varying loading on tendon
cells in different regions, it m a ye x p l a i nw h yp o s t e r i o r
proximal patellar tendon is pathological in patellar ten-
dinopathy. Peritendinous structures may be disturbed to
different extents in the healing response to tendon
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“paratenonitis” or tendon adhesion. Investigations of
how these factors affect tendon healing could help to
further elucidate the mechanism of failed healing. The
recent discovery of tendon-derived stem cells and char-
acterization of pathological tissues of tendinopathy have
provided evidences to support the ideas of erroneous
cell differentiation that contribute to failed tendon heal-
ing. According to this theory of pathogenesis, we shall
have a theoretical framework to develop a more repre-
sentative animal model of tendinopathy for further
study and verification. New ideas for treatments of ten-
dinopathy may be inspired based on this theory, for
example, a treatment which could override on the failed
healing tissues and restart the healing process.
Missing links and limitations
As compared to previous theories of pathogenesis for
tendinopathy which described a viscous cycle of inade-
quate repair and increased susceptibility of further inju-
ries, this new theory attempts to describe the “vicious
cycle” as an interaction between the vulnerability of the
healing process to noxious mechanical and biochemical
environments. Thus we can investigate the missing links
as predicted in the theory, for example, the impact of
mechanical stimulation on the cell differentiation of
healing tendons cells, and the disturbances in cytokines
triggered by re-injury on healing tendons. However,
there are still some limitations in the current pathogen-
esis theory. Firstly, tendinopathies in different tendons
exhibited specific patterns of affected regions and differ-
ent forms of matrix disturbance, which may be presum-
ably accounted by variations in local mechanical
environment and vascular supplies; but it is difficult to
explain for these variations at the present stage. Sec-
ondly, the interplay among innervations, increased noci-
ception and tendon healing is unknown. It is still a
black box for the mechanism of increased nociception
by failed tendon healing. The factors which govern the
development of chronic pain in tendinopathic tendons
remain obscure. Finally, the interactions between healing
tendons and the peritendinous tissues are seldom inves-
tigated and it is difficult to evaluate the potential invol-
vement of peritendinous tissues in the development of
tendinopathy.
Conclusions
In summary, we propose a unified theory for pathogen-
esis of tendinopathy which explain most of the available
experimental data about tendinopathy. It is a just a start
to probe into the nature of the pathology and we cer-
tainly wait for new findings and challenges to this theory
until we finally find the truth.
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